<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6595446\results\search\tropicalVirus\results.xml">
  <result pre="Development of an Enzyme-Linked Immunosorbent Assay for Rapid Detection of" exact="Dengue" post="Virus (DENV) NS1 and Differentiation of DENV Serotypes during"/>
  <result pre="Rapid Detection of Dengue Virus (DENV) NS1 and Differentiation of" exact="DENV" post="Serotypes during Early Infection ELISA for DENV NS1 Lai"/>
  <result pre="and Differentiation of DENV Serotypes during Early Infection ELISA for" exact="DENV" post="NS1 Lai et al. LaiSzu-ChiaaHuangYu-YineaShuPei-YunbChangShu-FenbHsiehPo-ShiuanaWeyJiunn-JyeaTsaiMeng-HungaBenRen-JycHsuYi-MingcFangYi-ChiendHsiaoMei-LingeLinChang-Chia[a], Institute of Preventive Medicine,"/>
  <result pre="rapid detection of dengue virus (DENV) NS1 and differentiation of" exact="DENV" post="serotypes during early infection. J Clin Microbiol 57:e00221-19. https://doi.org/10.1128/JCM.00221-19."/>
  <result pre="the terms of the Creative Commons Attribution 4.0 International license.JCM.00221-19.pdf" exact="Dengue" post="fever, caused by infections with the dengue virus (DENV),"/>
  <result pre="well as decrease the risk of wider outbreaks. Abstract ABSTRACT" exact="Dengue" post="fever, caused by infections with the dengue virus (DENV),"/>
  <result pre="rapid detection of NS1 antigens and the simultaneous differentiation of" exact="DENV" post="serotypes. A total of 146 serum samples obtained from"/>
  <result pre="from patients suspected to be in the acute phase of" exact="DENV" post="infection were used to evaluate the clinical application of"/>
  <result pre="sensitivity rates for serotyping were as follows: 88.2% (15/17) for" exact="DENV" post="serotype 1 (DENV1), 94.7% (18/19) for DENV2, 75% (12/16)"/>
  <result pre="stages of infection. These results indicate that our ELISA for" exact="DENV" post="NS1 is a convenient tool that may help elucidate"/>
  <result pre="a convenient tool that may help elucidate the epidemiology of" exact="DENV" post="outbreaks and facilitate the clinical management of DENV infections."/>
  <result pre="epidemiology of DENV outbreaks and facilitate the clinical management of" exact="DENV" post="infections. KEYWORDS dengue ELISA NS1 clinical diagnosis serotype typing"/>
  <result pre="and indirect) has been estimated to be $8.9 billion (7)." exact="Dengue" post="fever can be caused by any one of four"/>
  <result pre="of the onset of fever), in which the serotype of" exact="DENV" post="can be confirmed; however, these methods require special equipment"/>
  <result pre="provides a wide window for dengue virus detection (25, 29)." exact="Dengue" post="virus NS1 detection systems (ELISA and lateral flow assays)"/>
  <result pre="particular serotype of dengue virus) to create our ELISA for" exact="DENV" post="NS1 that can simultaneously detect the NS1 antigen and"/>
  <result pre="The clinical diagnostic benefits and utilities of our ELISA for" exact="DENV" post="NS1 include the identification of patients at risk of"/>
  <result pre="in areas where multiple serotypes cocirculate. As our ELISA for" exact="DENV" post="NS1 is a simple and straightforward assay that has"/>
  <result pre="(JEV) strain SA14-14-2 was propagated in BHK-21 cells, and the" exact="Zika" post="virus (ZIKV) ATCC VR 1843 strain was propagated in"/>
  <result pre="containing 2% FBS at 37°C for 2 to 3 days. (3)" exact="DENV" post="and JEV titers were determined via plaque assays in"/>
  <result pre="JEV titers were determined via plaque assays in BHK-21 cells." exact="ZIKV" post="titers were determined via plaque assays in Vero cells."/>
  <result pre="assays in Vero cells. Process of development of ELISA for" exact="DENV" post="NS1. The full details and methods of the process"/>
  <result pre="methods of the process of development of our ELISA for" exact="DENV" post="NS1 can be found in Fig. 1 and in"/>
  <result pre="the selection of MAb pairs to assemble our ELISA for" exact="DENV" post="NS1, the serotype-cross-reactive MAb that we named MAb53-1.1 was"/>
  <result pre="detection antibodies. FIG 1 Procedures in development of ELISA for" exact="DENV" post="NS1 (Dengue-type NS1 ELISA). Clinical samples. A total of"/>
  <result pre="a dengue virus-specific IgM/IgG capture ELISA, the commercially available Platelia" exact="Dengue" post="NS1 Ag ELISA kit (Bio-Rad, Marnes-la-Coquette, France), and our"/>
  <result pre="Ag ELISA kit (Bio-Rad, Marnes-la-Coquette, France), and our ELISA for" exact="DENV" post="NS1. Negative results for non-dengue viral infections were obtained"/>
  <result pre="RT-PCR, the dengue virus-specific IgM/IgG capture ELISA, and the Platelia" exact="Dengue" post="NS1 Ag ELISA. The study protocol was approved by"/>
  <result pre="rate of 0.1°C/s, during which the fluorescence was continuously read." exact="Dengue" post="virus-specific IgM/IgG capture ELISA. Each of the microplate wells"/>
  <result pre="the methods previously described by Shu et al. (38). Platelia" exact="Dengue" post="NS1 Ag ELISA. DENV NS1 proteins were detected in"/>
  <result pre="by Shu et al. (38). Platelia Dengue NS1 Ag ELISA." exact="DENV" post="NS1 proteins were detected in clinical serum samples using"/>
  <result pre="detected in clinical serum samples using the commercially available Platelia" exact="Dengue" post="NS1 Ag ELISA kit (Bio-Rad, Marnes-la-Coquette, France) in accordance"/>
  <result pre="were obtained. Testing clinical serum samples using the ELISA for" exact="DENV" post="NS1. Microwell plates were coated with 100 μl of 10-μg/ml"/>
  <result pre="50 negative serum samples were tested using our ELISA for" exact="DENV" post="NS1 by a second operator on a different day."/>
  <result pre="The sensitivity and specificity of serotyping by our ELISA for" exact="DENV" post="NS1 were compared with those of serotyping by RT-PCR."/>
  <result pre="serotyping by RT-PCR. The overall performances of our ELISA for" exact="DENV" post="NS1 and the Platelia Dengue NS1 Ag ELISA were"/>
  <result pre="performances of our ELISA for DENV NS1 and the Platelia" exact="Dengue" post="NS1 Ag ELISA were compared with the results from"/>
  <result pre="of 23 of these MAbs to the NS1 proteins of" exact="DENV" post="(5 MAbs against DENV1 NS1, 5 MAbs against DENV2"/>
  <result pre="from C6/36 cells infected with DENV. Establishment of ELISA for" exact="DENV" post="NS1. Our ELISA for DENV NS1 was established by"/>
  <result pre="DENV. Establishment of ELISA for DENV NS1. Our ELISA for" exact="DENV" post="NS1 was established by identifying the optimal MAb combinations,"/>
  <result pre="infected with DENVs) and specificity (ability to differentiate among the" exact="DENV" post="serotypes). As shown in Fig. 2, we selected four"/>
  <result pre="sensitivity and a high specificity to establish our ELISA for" exact="DENV" post="NS1. The four MAbs presenting serotype-specific reactivity to DENVs"/>
  <result pre="provided strong specificity in differentiating among the four serotypes of" exact="DENV" post="and presented no signs of reactivity with JEV or"/>
  <result pre="DENV and presented no signs of reactivity with JEV or" exact="ZIKV" post="NS1 (Fig. 3A to H). We subsequently selected MAb53-1.1"/>
  <result pre="was assessed in terms of the ability to differentiate among" exact="DENV" post="serotypes: DENV1 (MAb12-4.1), DENV2 (MAb33-7.1), DENV3 (MAb43-1.3), and DENV4"/>
  <result pre="1 Characterization of reactions between MAb and NS1 proteins of" exact="DENV" post="Hybridoma Isotype Type of epitope Reactivity of the four"/>
  <result pre="DENV Hybridoma Isotype Type of epitope Reactivity of the four" exact="DENV" post="serotypes by: Specificity Western blottinga ELISAb DENV1 DENV2 DENV3"/>
  <result pre="Vero cells infected with DENV1, DENV2, DENV3, DENV4, JEV, or" exact="ZIKV" post="were used as NS1 antigen sources, and the supernatant"/>
  <result pre="To determine the baseline detection limits of our ELISA for" exact="DENV" post="NS1, we performed 2-fold serial dilutions of immunoaffinity-purified DENV"/>
  <result pre="for DENV NS1, we performed 2-fold serial dilutions of immunoaffinity-purified" exact="DENV" post="NS1 proteins using blocking buffer, in which bovine serum"/>
  <result pre="supplemental material). The minimum detection levels of our ELISA for" exact="DENV" post="NS1 were determined to be between 1 and 4 ng/ml,"/>
  <result pre="contrast, the minimum detection levels achieved by the commercial Platelia" exact="Dengue" post="NS1 Ag ELISA, which were determined at the same"/>
  <result pre="demonstrates the superiority of our ELISA for the detection of" exact="DENV" post="NS1 in terms of sensitivity. TABLE 2 Detection limits"/>
  <result pre="terms of sensitivity. TABLE 2 Detection limits of ELISA for" exact="DENV" post="NS1 and Platelia Dengue NS1 Ag ELISAa NS1 detection"/>
  <result pre="2 Detection limits of ELISA for DENV NS1 and Platelia" exact="Dengue" post="NS1 Ag ELISAa NS1 detection assay Minimum detectable concn"/>
  <result pre="of NS1 proteins from: DENV1 DENV2 DENV3 DENV4 ELISA for" exact="DENV" post="NS1 1.953 3.906 3.906 0.977 Platelia Dengue NS1 Ag"/>
  <result pre="DENV4 ELISA for DENV NS1 1.953 3.906 3.906 0.977 Platelia" exact="Dengue" post="NS1 Ag ELISA 3.906 31.250 0.977 7.813 aThe sensitivities"/>
  <result pre="3.906 31.250 0.977 7.813 aThe sensitivities of the ELISA for" exact="DENV" post="NS1 and the commercial Platelia Dengue NS1 Ag ELISA"/>
  <result pre="of the ELISA for DENV NS1 and the commercial Platelia" exact="Dengue" post="NS1 Ag ELISA for NS1 detection were determined. The"/>
  <result pre="also evaluated the specificity and sensitivity of our ELISA for" exact="DENV" post="NS1 using clinical serum samples. The analysis involved the"/>
  <result pre="real-time RT-PCR, the dengue virus-specific IgM/IgG capture ELISA, the Platelia" exact="Dengue" post="NS1 Ag ELISA, and our ELISA for DENV NS1."/>
  <result pre="the Platelia Dengue NS1 Ag ELISA, and our ELISA for" exact="DENV" post="NS1. Following RT-PCR analysis, we found that 61 serum"/>
  <result pre="with the dengue virus-specific IgM/IgG capture ELISA and the Platelia" exact="Dengue" post="NS1 Ag ELISA, and our ELISA for DENV NS1"/>
  <result pre="the Platelia Dengue NS1 Ag ELISA, and our ELISA for" exact="DENV" post="NS1 method subsequently identified these to be positive for"/>
  <result pre="RT-PCR, the dengue virus-specific IgM/IgG capture ELISA, and the Platelia" exact="Dengue" post="NS1 Ag ELISA (Table 3). Among the 146 serum"/>
  <result pre="Platelia NS1 Ag ELISA was used, whereas our ELISA for" exact="DENV" post="NS1 identified 56 positive samples (15, 23, 12, and"/>
  <result pre="from the serotyping RT-PCR, the sensitivities of our ELISA for" exact="DENV" post="NS1 were as follows: 88.2% (15/17), 94.7% (18/19), 75%"/>
  <result pre="indicating a serotype specificity of 100%. Furthermore, our ELISA for" exact="DENV" post="NS1 correctly identified all 80 serum samples from patients"/>
  <result pre="These results clearly demonstrate the efficacy of our ELISA for" exact="DENV" post="NS1 method for the detection of DENV NS1 and"/>
  <result pre="our ELISA for DENV NS1 method for the detection of" exact="DENV" post="NS1 and its ability to discriminate among serotypes of"/>
  <result pre="DENV NS1 and its ability to discriminate among serotypes of" exact="DENV" post="in serum specimens, even during the acute phase of"/>
  <result pre="DENV in serum specimens, even during the acute phase of" exact="DENV" post="infection, as early as day 1 after the onset"/>
  <result pre="of illness (Table 3). Despite the fact that the Platelia" exact="Dengue" post="NS1 Ag ELISA and our ELISA for DENV NS1"/>
  <result pre="the Platelia Dengue NS1 Ag ELISA and our ELISA for" exact="DENV" post="NS1 achieved similar sensitivities (55 and 56 positive serum"/>
  <result pre="clinical serum samples by serotyping RT-PCR, IgM/IgG capture ELISA, Platelia" exact="Dengue" post="NS1 Ag ELISA, and ELISA for DENV NS1 Day"/>
  <result pre="capture ELISA, Platelia Dengue NS1 Ag ELISA, and ELISA for" exact="DENV" post="NS1 Day after onset of illness that serum was"/>
  <result pre="ELISAc Platelia dengue NS1 Ag ELISA (total n = 55)" exact="Dengue" post="viral infectionsd Non-dengue viral infectionse ELISA for DENV NS1"/>
  <result pre="= 55) Dengue viral infectionsd Non-dengue viral infectionse ELISA for" exact="DENV" post="NS1 (total n = 56) DENV1 DENV2 DENV3 DENV4"/>
  <result pre="using a dengue virus-specific IgM/IgG capture ELISA and the Platelia" exact="Dengue" post="NS1 Ag ELISA. dPositive results were obtained using RT-PCR"/>
  <result pre="or a dengue virus-specific IgM/IgG capture ELISA and the Platelia" exact="Dengue" post="NS1 Ag ELISA. eNegative results were obtained using RT-PCR,"/>
  <result pre="RT-PCR, a dengue virus-specific IgM/IgG capture ELISA, and the Platelia" exact="Dengue" post="NS1 Ag ELISA. TABLE 4 Performance of ELISA for"/>
  <result pre="Dengue NS1 Ag ELISA. TABLE 4 Performance of ELISA for" exact="DENV" post="NS1 and Platelia Dengue NS1 ELISA for detection of"/>
  <result pre="TABLE 4 Performance of ELISA for DENV NS1 and Platelia" exact="Dengue" post="NS1 ELISA for detection of NS1 in acute-phase sera"/>
  <result pre="serum samples No. of serum samples positive by: ELISA for" exact="DENV" post="NS1 (n = 56) Platelia Dengue NS1 Ag ELISA"/>
  <result pre="positive by: ELISA for DENV NS1 (n = 56) Platelia" exact="Dengue" post="NS1 Ag ELISA (n = 55) DENV1 D2ENV DENV3"/>
  <result pre="using a dengue virus-specific IgM/IgG capture ELISA and the Platelia" exact="Dengue" post="NS1 Ag ELISA. cNegative results were obtained using the"/>
  <result pre="RT-PCR, the dengue virus-specific IgM/IgG capture ELISA, and the Platelia" exact="Dengue" post="NS1 Ag ELISA. TABLE 5 Serotype specificity and sensitivity"/>
  <result pre="ELISA. TABLE 5 Serotype specificity and sensitivity of ELISA for" exact="DENV" post="NS1 for the detection of NS1 in acute-phase sera"/>
  <result pre="DENV NS1 for the detection of NS1 in acute-phase sera" exact="DENV" post="serotype No. of serum samples with the following results:"/>
  <result pre="6 illustrates the overall diagnostic performances of our ELISA for" exact="DENV" post="NS1 method and the Platelia Dengue NS1 Ag ELISA"/>
  <result pre="of our ELISA for DENV NS1 method and the Platelia" exact="Dengue" post="NS1 Ag ELISA (of the 146 clinical serum samples,"/>
  <result pre="were from patients with non-dengue viral infections). Our ELISA for" exact="DENV" post="NS1 achieved a diagnostic accuracy of 93.15% (95% CI,"/>
  <result pre="88.89% (95% CI, 80.51 to 94.54%). In contrast, the Platelia" exact="Dengue" post="NS1 Ag ELISA achieved a diagnostic accuracy of 92.47%"/>
  <result pre="TABLE 6 Overall diagnostic accuracy and sensitivity of ELISA for" exact="DENV" post="NS1 and Platelia dengue NS1 Ag ELISAa ELISA No."/>
  <result pre="PPV (% [95% CI]) NPV (% [95% CI]) ELISA for" exact="DENV" post="NS1 56 84.85 (73.9–92.49) 100 (95.49–100) 93.15 (87.76–96.67) 100"/>
  <result pre="Reproducibility. Clinical serum samples were retested with our ELISA for" exact="DENV" post="NS1 by a second operator on a different day."/>
  <result pre="tested a total of 57 samples that were positive for" exact="DENV" post="(16, 17, 16, and 8 samples positive for DENV1"/>
  <result pre="negative result, thereby illustrating the reproducibility of our ELISA for" exact="DENV" post="NS1. DISCUSSION Dengue virus infections range from asymptomatic or"/>
  <result pre="illustrating the reproducibility of our ELISA for DENV NS1. DISCUSSION" exact="Dengue" post="virus infections range from asymptomatic or mild to severe"/>
  <result pre="disease. The capture ELISA and the lateral flow assay for" exact="DENV" post="NS1 are easy to use, highly specific, and inexpensive,"/>
  <result pre="paired with a DENV-cross-reactive MAb to enable the detection of" exact="DENV" post="NS1. The use of multiplexed fluorescent microsphere beads, however,"/>
  <result pre="of the four serotype-specific MAbs-HRP to create our ELISA for" exact="DENV" post="NS1. As a result, we established a serotyping assay"/>
  <result pre="study are outlined in the following. (i) Our ELISA for" exact="DENV" post="NS1 was sensitive, with the lowest detectable concentration of"/>
  <result pre="4 ng/ml. (ii) The assay was specific, as our ELISA for" exact="DENV" post="NS1 was able to discriminate the four dengue virus"/>
  <result pre="mutual cross-reactivity and no cross-reactivity with Japanese encephalitis virus or" exact="Zika" post="virus (determined using supernatants of Vero cell cultures infected"/>
  <result pre="virus (determined using supernatants of Vero cell cultures infected with" exact="DENV" post="serotypes 1 to 4, JEV, and ZIKV). (iii) We"/>
  <result pre="We evaluated the sensitivity and accuracy of our ELISA for" exact="DENV" post="NS1 by applying it to clinical serum samples from"/>
  <result pre="DENV1 to DENV4, respectively. In other words, our ELISA for" exact="DENV" post="NS1 was able to identify the specific serotype of"/>
  <result pre="positive following analysis by the dengue IgM/IgG test and Platelia" exact="Dengue" post="NS1 Ag ELISA kit. Our ELISA for DENV NS1"/>
  <result pre="and Platelia Dengue NS1 Ag ELISA kit. Our ELISA for" exact="DENV" post="NS1 then determined that all five of these samples"/>
  <result pre="cross-reactivity with the NS1 proteins of Japanese encephalitis virus or" exact="Zika" post="virus derived from the supernatant from cells in culture,"/>
  <result pre="with viruses other than DENV, such as Japanese encephalitis virus," exact="Zika" post="virus, or West Nile virus. At present, there are"/>
  <result pre="than DENV, such as Japanese encephalitis virus, Zika virus, or" exact="West Nile" post="virus. At present, there are no West Nile cases"/>
  <result pre="virus, or West Nile virus. At present, there are no" exact="West Nile" post="cases and only a few imported Zika cases in"/>
  <result pre="are no West Nile cases and only a few imported" exact="Zika" post="cases in Taiwan. This is a limitation of our"/>
  <result pre="is a limitation of our study. Moreover, our ELISA for" exact="DENV" post="NS1 could be a tool to determine the number"/>
  <result pre="be a tool to determine the number and identity of" exact="DENV" post="serotypes during situations of DENV coinfection. In Taiwan, there"/>
  <result pre="the number and identity of DENV serotypes during situations of" exact="DENV" post="coinfection. In Taiwan, there have been reports of local"/>
  <result pre="local dengue outbreaks caused by different serotypes and genotypes of" exact="DENV" post="as well as by the cocirculation of more than"/>
  <result pre="as well as by the cocirculation of more than one" exact="DENV" post="serotype at any given time (43–46). The Centers for"/>
  <result pre="region, which is ideally suited to the spread of different" exact="DENV" post="serotypes brought in by travelers returning from regions in"/>
  <result pre="serotype only partially neutralize other serotypes. In fact, an initial" exact="DENV" post="infection increases the likelihood that a second DENV infection"/>
  <result pre="an initial DENV infection increases the likelihood that a second" exact="DENV" post="infection with another serotype will develop into severe disease"/>
  <result pre="It is worth noting that the chance of a second" exact="DENV" post="infection developing into severe dengue disease is also associated"/>
  <result pre="typically presents the greatest danger. Interestingly, a third or fourth" exact="DENV" post="infection usually presents as only a mild or asymptomatic"/>
  <result pre="in regions with limited resources are difficult. Our ELISA for" exact="DENV" post="NS1 is capable of detecting DENV NS1 antigens rapidly"/>
  <result pre="difficult. Our ELISA for DENV NS1 is capable of detecting" exact="DENV" post="NS1 antigens rapidly in the early stage and identifying"/>
  <result pre="commercial NS1 diagnostic tests. We believe that our ELISA for" exact="DENV" post="NS1 could be especially beneficial in regions where medical"/>
  <result pre="severe dengue disease. Finally, the implementation of our ELISA for" exact="DENV" post="NS1 could improve epidemiological surveillance, outbreak monitoring, clinical management,"/>
  <result pre="history. Trends Microbiol22:138–146. doi:10.1016/j.tim.2013.12.011.24468533 15.YamashitaA, SakamotoT, SekizukaT, KatoK, TakasakiT, KurodaM2016DGV:" exact="Dengue" post="Genographic Viewer. Front Microbiol7:75. doi:10.3389/fmicb.2016.00875.26925032 16.GuzmanMG, HalsteadSB, ArtsobH, BuchyP,"/>
 </snippets>
</snippetsTree>
